CXCR2 and neoplasm: In summary, the current study highlights a novel role of CXCR2 signaling in mediating KRAS(G12D) mutation-induced autocrine growth transformation of tumor cells by directly modulating the levels of KRAS protein and its downstream signaling (Figure 8).